Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Metergoline

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
Metergoline
Clinical data
Trade namesContralac, Liserdol
Other namesMethergoline; FI-6337; [(8β)-1,6-Dimethylergolin-8-yl)methyl]carbamic acid phenylmethyl ester
Routes of
administration
Oral
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
  • benzylN-[[(6aR,9S,10aR)-4,7-dimethyl-6,6a,8,9,10,10a-hexahydroindolo[4,3-fg]quinolin-9-yl]methyl]carbamate
CAS Number
PubChemCID
IUPHAR/BPS
ChemSpider
UNII
ChEBI
ChEMBL
CompTox Dashboard(EPA)
ECHA InfoCard100.037.881Edit this at Wikidata
Chemical and physical data
FormulaC25H29N3O2
Molar mass403.526 g·mol−1
3D model (JSmol)
  • O=C(OCc1ccccc1)NC[C@@H]3C[C@@H]4c5cccc2c5c(cn2C)C[C@H]4N(C3)C
  • InChI=1S/C25H29N3O2/c1-27-14-18(13-26-25(29)30-16-17-7-4-3-5-8-17)11-21-20-9-6-10-22-24(20)19(12-23(21)27)15-28(22)2/h3-10,15,18,21,23H,11-14,16H2,1-2H3,(H,26,29)/t18-,21+,23+/m0/s1 checkY
  • Key:WZHJKEUHNJHDLS-QTGUNEKASA-N checkY
 ☒NcheckY (what is this?)  (verify)

Metergoline (INNTooltip INN,BANTooltip British Approved Name), also known asmethergoline and sold under the brand namesContralac (veterinary) andLiserdol (clinical), is amonoaminergic medication of theergoline group which is used as aprolactin inhibitor in the treatment ofhyperprolactinemia (highprolactin levels) and to suppresslactation.[1][2][3]

Pharmacology

[edit]

Pharmacodynamics

[edit]

Metergoline is aligand of variousserotonin anddopamine receptors.[4][5][6][7][8][9]

Activities of metergoline at various sites[4][5][10][11][12][8]
SiteAffinity (Ki [nM])Efficacy (Emax [%])Action
5-HT1A4.3?Antagonist
5-HT1B5.2–36?Partial agonist
5-HT1D0.60–11.7?Partial agonist
5-HT1E776–1,122??
5-HT1F339–341??
5-HT2A0.12–2.3?Antagonist
5-HT2B0.71–1.8?Antagonist
5-HT2C0.18–1.8?Antagonist
5-HT3>5,000–7,400??
5-HT4354??
5-HT5A630??
5-HT5B1,000??
5-HT661–400??
5-HT76.4–6.5?Antagonist
D2??Agonist
Notes: All sites are human except 5-HT3 (rat/pig), 5-HT4 (pig), and 5-HT5B (rat—no human counterpart).[4]

References

[edit]
  1. ^Index Nominum 2000: International Drug Directory. Taylor & Francis. 2000. pp. 661–.ISBN 978-3-88763-075-1.
  2. ^Plumb DC (21 February 2018)."Metergoline".Plumb's Veterinary Drug Handbook: Pocket. John Wiley & Sons. pp. 1057–.ISBN 978-1-119-34649-4.
  3. ^Johson CA (2 December 2008)."False Pregnancy, Disorders of Pregnancy and Parturition, and Mismating". In Nelson RW, Couto CG (eds.).Small Animal Internal Medicine - E-Book. Elsevier Health Sciences. pp. 927–.ISBN 978-0-323-06512-2.
  4. ^abc"PDSP Database - UNC".pdsp.unc.edu. Archived fromthe original on 16 April 2021. Retrieved15 January 2022.
  5. ^abHoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, et al. (June 1994). "International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin)".Pharmacological Reviews.46 (2):157–203.PMID 7938165.
  6. ^Hamon M, Mallat M, Herbet A, Nelson DL, Audinot M, Pichat L, Glowinski J (February 1981). "[3H]Metergoline: a new ligand of serotonin receptors in the rat brain".Journal of Neurochemistry.36 (2):613–626.doi:10.1111/j.1471-4159.1981.tb01634.x.PMID 7463079.S2CID 20259621.
  7. ^Miller KJ, King A, Demchyshyn L, Niznik H, Teitler M (September 1992). "Agonist activity of sumatriptan and metergoline at the human 5-HT1D beta receptor: further evidence for a role of the 5-HT1D receptor in the action of sumatriptan".European Journal of Pharmacology.227 (1):99–102.doi:10.1016/0922-4106(92)90149-P.PMID 1330643.
  8. ^abWebster J (December 1999). "Dopamine agonist therapy in hyperprolactinemia".The Journal of Reproductive Medicine.44 (12 Suppl):1105–1110.PMID 10649819.
  9. ^Glennon RA (January 1987). "Central serotonin receptors as targets for drug research".J Med Chem.30 (1):1–12.doi:10.1021/jm00384a001.PMID 3543362.Table II. Affinities of Selected Phenalkylamines for 5-HT1 and 5-HT2 Binding Sites
  10. ^Pertz H, Eich E (1999)."Ergot Alkaloids and their Derivatives as Ligands for Serotoninergic, Dopaminergic, and Adrenergic Receptors"(PDF).Ergot. pp. 432–462.doi:10.1201/9780203304198-21.ISBN 9780429219764. Archived fromthe original(PDF) on 2021-04-16.
  11. ^Pauwels PJ (September 1997). "5-HT 1B/D receptor antagonists".General Pharmacology.29 (3):293–303.doi:10.1016/s0306-3623(96)00460-0.PMID 9378233.
  12. ^Hutcheson JD, Setola V,Roth BL, Merryman WD (November 2011)."Serotonin receptors and heart valve disease--it was meant 2B".Pharmacology & Therapeutics.132 (2):146–157.doi:10.1016/j.pharmthera.2011.03.008.PMC 3179857.PMID 21440001.

External links

[edit]
Prolactin inhibitors
Anti-inflammatory products
forvaginal administration
Tocolytics/labor repressants (G02CA)
β2 adrenoreceptor agonists
Oxytocin antagonists
NSAIDs
Calcium channel blockers
Myosin inhibitors
D1-like
Agonists
PAMs
Antagonists
D2-like
Agonists
Antagonists
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Ergolines
(incl.lysergines)
Clavines
(6,8-dimethylergolines)
Lysergamides
(lysergic acid amides)
Ergopeptines
(peptide ergolines)
Partial ergolines
Related compounds
Natural sources
Retrieved from "https://en.wikipedia.org/w/index.php?title=Metergoline&oldid=1296121260"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp